☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Safety monitoring for 'flu antivirals

The Medicines and Healthcare products Regulatory Agency has announced the launch of a online reporting mechanism for monitoring the safety of the swine flu antiviral medicines.

It is expected that usage of oseltamivir (Tamiflu®) and zanamavir (Relenza®) will increase during the swine flu pandemic. The Swine 'Flu ADR Portal can be used by healthcare professionals and the public to reported suspected adverse drug reactions (ADR) to either of these drugs.

Action: Clinicians should be aware of this portal and recommend it to patients with suspected ADRs. Clinicians should report adverse events for patients without internet access.

Share 'Safety monitoring for 'flu antivirals' by emailShare 'Safety monitoring for 'flu antivirals' on FacebookShare 'Safety monitoring for 'flu antivirals' on TwitterShare 'Safety monitoring for 'flu antivirals' on LinkedInShare 'Safety monitoring for 'flu antivirals' on reddit


No Comments to “Safety monitoring for 'flu antivirals”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.